Author:
Stamatelopoulos K,Bramos D,Manios E,Alexaki E,Kaladaridou A,Georgiopoulos G,Koroboki E,Kolyviras A,Stellos K,Zakopoulos N,Toumanidis S
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Remuzzi G, Ruggenenti P . Overview of randomised trials of ACE inhibitors. Lancet 2006; 368: 555–556.
2. Jankowski P, Safar ME, Benetos A . Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system. Curr Pharm Des 2009; 15: 571–584.
3. Sanders GD, Coeytaux R, Dolor RJ, Hasselblad V, Patel UD, Powers B et al. Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality, 2011.
4. Nikolaidis LA, Doverspike A, Huerbin R, Hentosz T, Shannon RP . Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation 2002; 105: 2785–2790.
5. Aznaouridis KA, Stamatelopoulos KS, Karatzis EN, Protogerou AD, Papamichael CM, Lekakis JP . Acute effects of renin-angiotensin system blockade on arterial function in hypertensive patients. J Hum Hypertens 2007; 21: 654–663.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献